Novavax Altman Z-Score
Novavax Altman Z-Score Chart
Novavax Historical Altman Z-Score DataPro Data Export
There is no data for the selected date range.
About Altman Z-Score
CAUTION: The Altman Z-Score is meant to be applied only to manufacturing firms that are near bankruptcy. It was not based on a sample including non-manufacturing firms (service firms, banks, etc.). Use it at your own risk with those companies, but beware that bankruptcy probabilities may be misstated.
The Altman Z-Score helps investors to gauge the probability of a company going bankrupt. Generally, firms with a score above 3.00 have a low probability of bankruptcy, and those with a Z-Score of less than 1.81 have a relatively high probability of bankruptcy.
Note that this is a probabilistic model, so it will not classify perfectly.
The score was first published in a 1968 paper by Edward Altman titled "Financial Ratios, Discriminant Analysis and the Prediction of Corporate Bankruptcy."
Altman re-tested the model in a 2000 paper titled "Predicting financial distress of companies: Revisiting the Z-score and Zeta models". The paper showed that the model still had utility for looking at manufacturers, though the number of misclassifications did increase over time.
View Altman Z-Score for NVAX.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
NVAX Altman Z-Score Benchmarks
|Sinovac Biotech||Go Pro|
|Biocryst Pharmaceuticals||Go Pro|
|Hemispherx Biopharma||Go Pro|
NVAX Altman Z-Score Rankings
1377 of 8002
198 of 684 in Healthcare
56 of 248 in Biotechnology
NVAX Altman Z-Score Range, Past 5 Years
|Minimum||Go Pro||Mar 2012|
|Maximum||Go Pro||Jun 2011|
PR Newswire May 20
GlobeNewswire May 10
Seeking Alpha May 7
Street Insider May 7
GlobeNewswire May 7